SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-092209
Filing Date
2023-04-05
Accepted
2023-04-05 16:06:01
Documents
20
Period of Report
2023-03-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d462703d8k.htm   iXBRL 8-K 27236
2 EX-99.1 d462703dex991.htm EX-99.1 736355
6 GRAPHIC g462703g00a36.jpg GRAPHIC 747
7 GRAPHIC g462703g35p49.jpg GRAPHIC 422472
8 GRAPHIC g462703g54q31.jpg GRAPHIC 768
9 GRAPHIC g462703g62o01.jpg GRAPHIC 369224
10 GRAPHIC g462703g67w74.jpg GRAPHIC 234920
11 GRAPHIC g462703g77t27.jpg GRAPHIC 778
12 GRAPHIC g462703g82c32.jpg GRAPHIC 746
  Complete submission text file 0001193125-23-092209.txt   2334641

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lhdxq-20230322.xsd EX-101.SCH 2525
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lhdxq-20230322_lab.xml EX-101.LAB 17986
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lhdxq-20230322_pre.xml EX-101.PRE 11243
14 EXTRACTED XBRL INSTANCE DOCUMENT d462703d8k_htm.xml XML 3497
Mailing Address 1315 63RD STREET EMERYVILLE CA 94608
Business Address 1315 63RD STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Filer) CIK: 0001652724 (see all company filings)

IRS No.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39976 | Film No.: 23802532
SIC: 2835 In Vitro & In Vivo Diagnostic Substances